Physician profile
Abdul Q Memon
NPI 1093781346
$12,964.52
in general payments reported to CMS, 2019-2025
39 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $299 · 2021: $522 · 2022: $451 · 2023: $211 · 2024: $694 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,180 · Food and Beverage: $1,761 · Travel and Lodging: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,180.00 |
| Food and Beverage | $1,760.73 |
| Travel and Lodging | $276.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $9,612.04 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Abbott Laboratories | $522.10 | 2020-2023 | Mitraclip |
| Boston Scientific Corporation | $336.88 | 2019-2024 | Varithena Administration Pack |
| Shockwave Medical, INC | $188.16 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $187.69 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $185.56 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $185.42 | 2024-2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.42 | 2020-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $144.03 | 2019-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $122.82 | 2023-2025 | Verquvo |
| Medtronic, INC. | $121.84 | 2021-2025 | Symplicity G3, Ffrangio, Venaseal |
| E.R. Squibb & Sons, L.L.C. | $101.64 | 2024-2025 | Eliquis, Camzyos |
| Abiomed | $88.92 | 2020-2021 | |
| Bardy Diagnostics, INC. | $85.00 | 2020-2022 | |
| Amgen INC. | $78.46 | 2019-2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $69.73 | 2024-2025 | |
| Tactile Systems Technology INC | $69.35 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Janssen Pharmaceuticals, INC | $68.06 | 2020-2022 | |
| Zoll Respicardia, INC. | $61.59 | 2025 | Remede System |
| Cagent Vascular INC | $61.30 | 2025 | Serrantor |
| Kiniksa Pharmaceuticals International, Plc | $60.22 | 2024 | Arcalyst |
| Baxter Healthcare | $47.70 | 2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Pfizer INC. | $44.24 | 2019-2023 | |
| Biotronik INC. | $40.85 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.16 | 2025 | |
| Medtronic Vascular, INC. | $25.99 | 2019 | |
| Daiichi Sankyo INC. | $24.85 | 2023 | Injectafer |
| Novo Nordisk INC | $24.17 | 2024 | Ozempic |
| Gilead Sciences, INC. | $23.97 | 2019 | |
| Watermark Medical, INC. | $22.53 | 2020 | |
| Astellas Pharma US INC | $20.39 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $18.77 | 2024 | Rhythm Express |
| Impulse Dynamics (USA) INC. | $17.71 | 2022 | |
| Scpharmaceuticals INC. | $17.09 | 2024 | |
| Infobionic, INC | $16.29 | 2024 | Mome Device |
| Elutia, INC. | $15.96 | 2025 | Ecm Patch,Pouch |
| Alnylam Pharmaceuticals INC. | $14.33 | 2025 | Amvuttra |
| Inspire Medical Systems, INC. | $13.76 | 2025 | Inspire |
| Cardinal Health 200 LLC | $13.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Memon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.